Retour
Prix Enlivex Therapeutics Ltd (ENLV)
Graphique du cours de l'action ENLV
ENLV Gagner
Enlivex Therapeutics Ltd
$0.94
0.66%
$0
À la fermeture : Jan 16, 16:00:00 GMT-5
$0.93
-0.71%
$0
Post-Marché: Jan 16, 20:00:00 GMT-5
Statistiques clés
Clôture préc.
$0.9338
Prix d'ouverture
$0.97
Plage de la journée
$0.9331 - $0.9863
Plage de 52 semaines
$0.66 - $2.1
Volume
379.2K
Volume moyen
3.9M
BPA (TTM)
-0.55
Rendement en dividend
--
Capitalisation boursière
$220.5M
Qu’est-ce que ENLV ?
Enlivex Therapeutics Ltd. engages in the development of macrophage reprogramming immunotherapy products. AllocetraTM is a therapy designed to reprogram macrophages into their homeostatic state. Diseases such as solid cancers, sepsis, COVID-19 and many others reprogram macrophages out of their homeostatic state. These non-homeostatic macrophages contribute significantly to the severity of the respective diseases. By restoring macrophage homeostasis, AllocetraTM has the potential to provide immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents.
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved